Eczema is rarely framed as a mental health emergency — but for children and adolescents living with atopic dermatitis, the psychological toll may be far more severe than clinicians and parents typically recognize. A systematic review now quantifies just how much greater that burden is compared to adults, offering the clearest age-stratified picture of this risk to date.
Drawing on 28 observational studies sourced from PubMed, Embase, and the Cochrane Library (literature through October 2025), this PROSPERO-registered meta-analysis calculated pooled hazard ratios and odds ratios using random-effects models across pediatric, adolescent, and adult cohorts. For depression, youth with atopic dermatitis showed a pooled hazard ratio of 2.16 (95% CI: 1.56–2.98) in cohort studies — compared to just 1.32 (95% CI: 1.23–1.41) in adults. Cross-sectional data amplified that gap further, with pediatric odds ratios reaching 2.79 versus 1.61 in adults. Anxiety followed the same developmental gradient, and younger patients also demonstrated elevated suicidality risk. All estimates carried wide prediction intervals and substantial heterogeneity (I² values frequently exceeding 90%), signaling meaningful variability across study populations and methodologies.
This finding sits within a growing literature recognizing atopic dermatitis as a systemic inflammatory condition with neuropsychiatric dimensions, not merely a skin disease. The itch-scratch cycle disrupts sleep architecture, chronic inflammation intersects with HPA-axis dysregulation, and the social stigma of visible lesions during formative developmental years may compound biological vulnerabilities in ways that adults — with more established coping mechanisms — partly buffer. The extraordinary heterogeneity here is a critical caveat: most included studies are observational, making causality indeterminate, and diagnostic ascertainment for both AD severity and psychiatric outcomes varies considerably. Still, the consistency of the age gradient across depression, anxiety, and suicidality across multiple study designs strengthens the signal. Clinically, this argues for integrating routine mental health screening into pediatric dermatology workflows — not as optional, but as standard of care.